Skip to main content
CRVLCorVel Corp.Sell4.6·$60.57-0.36%
Open full analysis

CorVel Corp. (CRVL) Stock Analysis

Range Bound setup

SellVALUE-TRAP 2/5High Confidence

Financial Services · Insurance Brokers

Sell if holding. Multiple concerning factors at $60.57: Leverage penalty (D/E 7.1): -1.5; Consecutive earnings misses (4).

CorVel Corporation provides workers' compensation managed care and medical cost containment services — including bill review, PPO network management, utilization management, case management, and pharmacy services — nationwide to insurers, TPAs, and self-insured employers.... Read more

$60.57+4.2% A.UpsideScore 4.6/10#11 of 11 Insurance Brokers
QualityF-score7 / 9FCF yield3.01%
Stop $56.33Target $63.09(resistance)A.R:R 0.0:1

Sell if holding. Multiple concerning factors at $60.57: Leverage penalty (D/E 7.1): -1.5; Consecutive earnings misses (4). Chart setup: RSI 43 mid-range, Bollinger mid-band. Score 4.6/10, high confidence.

Passes 6/10 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 52d clear, semi cycle peak clear, materials cycle peak clear). Fails on death cross (50MA < 200MA). Suitability: aggressive.

10-K grounded · weekly refresh

About CorVel Corp.

About CorVel Corp.

CorVel Corporation delivers medical cost containment and managed care services for workers' compensation, automobile insurance, and group health claims through a nationwide branch network backed by a primary data center in Portland, Oregon, and a redundancy center in Lone Mountain, Nevada. The proprietary PPO network exceeded 1.2 million providers at March 31, 2026. No single customer accounted for 10% or more of revenue in fiscal years 2026, 2025, or 2024, with clients spanning insurers, TPAs, government entities, and self-insured employers.

CorVel earns service fees through three delivery modes: fully integrated claims-management programs for self-insured employers seeking a single partner, discrete standalone modules for large insurance carriers or TPAs, and targeted add-on services that extend existing client workflows. The bill review platform uses an AI rules engine with over 100 million individual rules to automate claim adjudication and generate savings reports via the CareMC portal. Pharmacy services, directed care networks, case management, and vocational rehabilitation round out the service stack. Competitors include national managed care providers, TPAs, PPOs, and insurance carriers that perform managed care in-house. The Bureau of Labor Statistics reported 2.34 million occupational injuries in 2024, below the pre-pandemic 2019 count of 2.69 million, though CorVel has expanded market share even as total claims volume remains below pre-pandemic levels.

Show full overview

Workers' compensation managed care is subject to state-specific statutes and court decisions that vary extensively across jurisdictions, governing claims handling, benefit amounts, and cost-control strategies. The 10-K identifies legislative reform risk — states have considered but not enacted provisions that would allow employers to designate HMOs or PPOs to cover workers' compensation claimants, which could intensify competition from health plans with existing managed-care capabilities. In May 2026, CorVel disclosed via Form 8-K that Michael Combs, Chairman, CEO, and President for 34 years, will transition to Executive Chair effective July 1, 2026, with Sarah Scott appointed as incoming CEO and President.

See also: Financial Services · Insurance Brokers

From CorVel Corp.'s most recent 10-K filing, extracted June 9, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-12

Recent Developments — CorVel Corp.

Material events (past 30 days)

  • 8K Jun 1, 2026 MEDIUM Item 5.02: Michael G. Combs (CEO, President, Chairman) transitioning to Executive Chair effective July 1, 2026. Sarah Scott appointed CEO and President effective July 1, 2026. Clean handoff; Combs continues as Executive Chair advising on transition.

Generated 2026-06-15T18:11:46Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Tue, Aug 4, 202652d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Leverage penalty (D/E 7.1): -1.5
Consecutive earnings misses (4)
Weak overall score: 4.6/10

Key Metrics

P/E (TTM)28.4
P/E (Fwd)
Mkt Cap$3.1B
EV/EBITDA16.4
Profit Mgn11.5%
ROE30.8%
Rev Growth7.4%
Beta0.98
DividendNone
Rating analysts

Quality Signals

Piotroski F7/9

Options Flow

P/C0.67bullish
IV66%elevated
Max Pain$45-25.7% vs spot

Material Events(8-K, last 90d)

  • 2026-06-01Item 5.02MEDIUM
    Michael G. Combs (CEO, President, Chairman) transitioning to Executive Chair effective July 1, 2026. Sarah Scott appointed CEO and President effective July 1, 2026. Clean handoff; Combs continues as Executive Chair advising on transition.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

3 floor-breakers

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Earnings History
0.0
Surprise Avg
0.0
Earnings Timing
5.0
Earnings concerns: 0B/4M

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
1.8
Value Rank
3.5
Quality Rank
5.3

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

52w Position
0.3
Support Resistance
4.6
Bollinger
4.7
GatesDeath cross (50MA < 200MA)Momentum 4.5<5.5 (soft — BUY_NOW allowed but watch)A.R:R UPSIDE_EXHAUSTED (upside=0.0%)Executive change: officer departure/appointmentMomentum 4.5>=4.5Insider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 52d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRange BoundSuitability: Aggressive
RSI
43 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $56.03Resistance $64.38

Price Targets

$56
$63
A.Upside+4.2%
A.R:R0.0:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Death cross — 50-day MA below 200-day MA

Earnings

M
M
M
M
0/4 beats
Next Earnings2026-08-04 (52d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CRVL stock a buy right now?

Sell if holding. Multiple concerning factors at $60.57: Leverage penalty (D/E 7.1): -1.5; Consecutive earnings misses (4). Chart setup: RSI 43 mid-range, Bollinger mid-band. Prior stop was $56.33. Score 4.6/10, high confidence.

What is the CRVL stock price target?

Take-profit target: $63.09 (+4.2% upside). Prior stop was $56.33. Stop-loss: $56.33.

What are the risks of investing in CRVL?

Leverage penalty (D/E 7.1): -1.5; Consecutive earnings misses (4); Weak overall score: 4.6/10.

Is CRVL overvalued or undervalued?

CorVel Corp. trades at a P/E of 28.4 (forward N/A). TrendMatrix value score: 5.0/10. Verdict: Sell.

0
What does CorVel Corp. do?CorVel Corporation provides workers' compensation managed care and medical cost containment services — including bill...

CorVel Corporation provides workers' compensation managed care and medical cost containment services — including bill review, PPO network management, utilization management, case management, and pharmacy services — nationwide to insurers, TPAs, and self-insured employers. Revenue is fee-based with no single client exceeding 10% of revenues in fiscal years 2026, 2025, or 2024.

Related stocks: BRO (Brown & Brown, Inc.) · WTW (Willis Towers Watson Public Lim) · GSHD (Goosehead Insurance, Inc.) · BWIN (The Baldwin Insurance Group, In) · ARX (Accelerant Holdings)
Home Stocks CRVL

Latest news

Latest News

Quiver Quantitative34d agoEarnings
Marketscreener.com34d agoEarnings
Sahm35d agoEarnings
AD HOC NEWS32d ago
Newser.com30d ago
AD HOC NEWS30d agoEarnings
The Chronicle-Journal31d ago
Benzinga14d agoLeadership Change
Benzinga26d agoEarnings
Benzinga26d agoEarnings
Benzinga26d agoEarnings